Literature DB >> 20130509

Laparoscopy-assisted vaginal versus abdominal hysterectomy in endometrial cancer.

Ho-Suap Hahn1, Hyun-Ja Kim, Seok-Geun Yoon, Woo-Chul Kim, Hong-Jun Choi, Hy-Sook Kim, Sung-Ran Hong, Yong-Soon Kwon, In-Ho Lee, Kyung-Taek Lim, Ki-Heon Lee, Jae-Uk Shim, Jung-Eun Mok, Tae-Jin Kim.   

Abstract

INTRODUCTION: The purpose of this study was to compare the efficacy of a laparoscopy-assisted surgical staging with a traditional laparotomy staging for the treatment of endometrial cancer.
METHODS: We retrospectively analyzed the medical records of 465 patients with endometrial adenocarcinoma treated by surgery between January 1996 and December 2007.
RESULTS: There were no significant differences between the laparoscopy and the laparotomy groups in age, body mass index, and histologic type. However, in the laparotomy group, grade and surgical stage were higher, the diseases were more chronic, and more postoperative adjuvant treatments were necessary. One hundred seven (76.4%) of 140 patients in the laparoscopy group and 260 (80.0%) of the 325 patients in the laparotomy group had lymphadenectomy, and the median numbers of pelvic and paraaortic lymph nodes obtained were not statistically different. The laparoscopy group showed shorter postoperative hospital stay and lower blood loss, and the operating time was also shorter than that in the laparotomy group. There was no significant difference in intraoperative or postoperative complications, and the operative technique did not influence survival rates after adjusting several confounding factors.
CONCLUSIONS: Our data of 12 years with a large number of patients show no differences in complications and impacts on survival between laparoscopy and laparotomy. Laparoscopy has advantages of shorter operating time and other advantages over laparotomy previously reported. Therefore, laparoscopy can be considered a good therapeutic option for endometrial cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20130509     DOI: 10.1111/IGC.0b013e3181bffb1b

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Current status in the management of uterine corpus cancer in Korea.

Authors:  Nan-Hee Jeong; Jong-Min Lee; Seon-Kyung Lee
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer.

Authors:  Tae Wook Kong; Kyung Mi Lee; Ji Yoon Cheong; Woo Young Kim; Suk-Joon Chang; Seung-Chul Yoo; Jong-Hyuck Yoon; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

3.  Asian society of gynecologic oncology workshop 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Mohamad Farid Aziz; Uma K Devi; Hextan Y S Ngan; Joo-Hyun Nam; Seung Cheol Kim; Tomoyasu Kato; Hee Sug Ryu; Shingo Fujii; Yoon Soon Lee; Jong Hyeok Kim; Tae-Joong Kim; Young Tae Kim; Kung-Liahng Wang; Taek Sang Lee; Kimio Ushijima; Sang-Goo Shin; Yin Nin Chia; Sarikapan Wilailak; Sang Yoon Park; Hidetaka Katabuchi; Toshiharu Kamura; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 4.  The incidence of postoperative symptomatic lymphocele after pelvic lymphadenectomy between abdominal and laparoscopic approach: a systemic review and meta-analysis.

Authors:  Jong Ha Hwang; Bo Wook Kim
Journal:  Surg Endosc       Date:  2022-04-25       Impact factor: 3.453

5.  Laparoscopic surgery for endometrial cancer: increasing body mass index does not impact postoperative complications.

Authors:  C William Helm; Cibi Arumugam; Mary E Gordinier; Daniel S Metzinger; Jianmin Pan; Shesh N Rai
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

6.  Laparoscopy Versus Laparotomy in the Treatment of High-Risk Endometrial Cancer: A Propensity Score Matching Analysis.

Authors:  Huiqiao Gao; Zhenyu Zhang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.